Suha Kadura is a Respiratory physician affiliated with University of Washington Medical Center. OpenAlex indexes 15 publications with 645 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1959 NE Pacific St
Seattle, WA 981952508
Telephone
206-520-5000Provider last certified this registry record 26 Sept 2023.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- United Therapeutics CorporationProgram year20252 payments
- United Therapeutics CorporationProgram year20241 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
61.4%Corticosteroid58.2%Prednisone100%Part D≥82 patientsProton pump inhibitor3.1%Omeprazole100%Part D<11 patientsCancer & immunology
31.1%Kinase inhibitor16.7%Ofev100%Part D≥16 patientsPyridone9.9%Pirfenidone100%Part D<11 patients+ 1 more class in this area
Respiratory
7.6%beta2-Adrenergic Agonist4.7%Albuterol Sulfate Hfa100%Part D<11 patientsCorticosteroid2.9%Breyna100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Interstitial Lung Disease with ANCA Positivity: A Retrospective Observational Study
SSRN Electronic Journal
2023 - Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management
European Respiratory Review
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Ganesh Raghu, MD
University of Washington Medical Center
Mark Wener
University of Washington Medical Center
Peter Leary, MD
University of Washington Medical Center
Ali Samii
University of Washington Medical Center
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”